Eye discomfort

Also known as: Ocular discomfort

Drug	Drug Name	Drug Description
DB11326	Boric acid	No FDA- or EMA-approved therapeutic indications on its own.
DB08818	Hyaluronic acid	A glycosaminoglycan used for the relief of joint pain, wound healing, ophthalmologic treatment, cosmetic treatment, and various other applications.
DB11063	Polysorbate 80	It is used as a solubilizer, antimicrobial preservative and disinfectant .
DB06764	Tetryzoline	An alpha-adrenergic agonist used in the temporary symptomatic relief of discomfort and redness of the eyes due to minor irritations, as well as alleviate nasal congestion.

Drug	Drug Name	Target	Type
DB08818	Hyaluronic acid	CD44 antigen	target
DB08818	Hyaluronic acid	Intercellular adhesion molecule 1	target
DB08818	Hyaluronic acid	Hyaluronan mediated motility receptor	target
DB08818	Hyaluronic acid	Neurocan core protein	target
DB08818	Hyaluronic acid	Versican core protein	target
DB08818	Hyaluronic acid	Complement component 1 Q subcomponent-binding protein, mitochondrial	target
DB08818	Hyaluronic acid	Hyaluronan and proteoglycan link protein 1	target
DB08818	Hyaluronic acid	Hyaluronan and proteoglycan link protein 3	target
DB08818	Hyaluronic acid	Hyaluronan-binding protein 2	target
DB08818	Hyaluronic acid	Layilin	target
DB08818	Hyaluronic acid	Stabilin-2	target
DB08818	Hyaluronic acid	Tumor necrosis factor-inducible gene 6 protein	target
DB08818	Hyaluronic acid	Interphotoreceptor matrix proteoglycan 2	target
DB08818	Hyaluronic acid	Intracellular hyaluronan-binding protein 4	target
DB08818	Hyaluronic acid	Hyaluronidase enzymes	enzyme
DB08818	Hyaluronic acid	Multidrug resistance-associated protein 5	transporter
DB08818	Hyaluronic acid	Lymphatic vessel endothelial hyaluronic acid receptor 1	target
DB06764	Tetryzoline	Alpha-1 adrenergic receptors	target
DB06764	Tetryzoline	Alpha-2 adrenergic receptors	target

Drug	Drug Name	Phase	Status	Count